Table: Sapporo Clinical Lab -Q1 group results

Sapporo Clinical Laboratory

08/08/2022 07:30

Aug 8 (Reuters)- 
             Sapporo Clinical Laboratory Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2022        Jun 30, 2021     Mar 31, 2023 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             4.90                4.64             19.36    
                 (+5.6 pct)          (+13.9 pct)      (+1.3 pct)  
  Operating        131 mln             292 mln            1.17    
                 (-55.0 pct)        (+762.5 pct)      (-24.2 pct) 
  Recurring        223 mln             293 mln            1.11    
                 (-23.9 pct)        (+638.0 pct)      (-30.8 pct) 
  Net              78 mln              107 mln          714 mln   
                 (-27.1 pct)                          (-31.5 pct) 
  EPS             23.35 yen           31.31 yen       213.01 yen  
  Ann Div                             23.00 yen        23.00 yen  
  -Q2 div                                NIL              NIL     
  -Q4 div                             23.00 yen        23.00 yen  
  
  NOTE - Sapporo Clinical Laboratory Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=9776.T